Header image

Session 2B: Radiopharmaceutical manufacturing in Australia

Tracks
Track 3
Wednesday, October 22, 2025
2:50 PM - 3:35 PM
Momentum Room

Overview

Sponsored by: TELIX


Details

Australia is becoming a leader in radiopharmaceutical manufacturing, with a focus on developing and manufacturing the next generation of therapeutic radiopharmaceuticals, particularly for cancer treatment, and producing short-lived radioisotopes and radiopharmaceuticals for positron emission tomography (PET) scans. This session brings together some key radiopharmaceuticals manufacturers from industry and research with the aim of positioning Australia as a world-leader in the field of radiopharmaceutical manufacture and innovation. Sponsored by:


Speaker

Agenda Item Image
Mr Chady Barkil
Director
South Australian Health and Medical Research Institute

Panellist

Agenda Item Image
Dr. Mark Frazzetto
Director of Products & Quality
Cyclotek Pty Ltd

Panellist

Agenda Item Image
Dr. Nat Lenzo
Founder and Managing Director
Cyclowest

Panellist

Agenda Item Image
Simone Leyden
Senior Director Global Public Affairs and Patient Advocacy
Telix Pharmaceuticals Limited

Panellist

Agenda Item Image
Dr. Gabriel Liberatore
Strategic Advisor
Glytherix

Chair

loading